Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China
· Delayed Price · Currency is CNY 7.93
+0.04 (0.51%)
Apr 30, 2026, 11:54 AM CST
SHE:300942 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 8.55 | 15.47 | 17.12 | -184.91 | 82.97 | 236.51 | Upgrade
|
| Depreciation & Amortization | 29.88 | 29.88 | 21.02 | 33.48 | 30.36 | 24.16 | Upgrade
|
| Other Amortization | 0.71 | 0.71 | 2.02 | 15.5 | 4.84 | 3.82 | Upgrade
|
| Loss (Gain) From Sale of Assets | -12.21 | -12.21 | -2.28 | -2.81 | -0.3 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.4 | 2.4 | 1.11 | 25.18 | 1.95 | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | 8.15 | 8.15 | 3.98 | 54.08 | -2.68 | -9.66 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 8.14 | 2.81 | 0.49 | 2.42 | Upgrade
|
| Other Operating Activities | 27.17 | 31.37 | 20.21 | 41.95 | 52.64 | 4.27 | Upgrade
|
| Change in Accounts Receivable | -20.55 | -20.55 | -20.85 | 24.71 | -29.25 | -38.91 | Upgrade
|
| Change in Inventory | -16.72 | -16.72 | 20.3 | 41.34 | -51.13 | -17.02 | Upgrade
|
| Change in Accounts Payable | 39.28 | 39.28 | -58.74 | -96.08 | 33.38 | 41.1 | Upgrade
|
| Change in Other Net Operating Assets | -3.92 | -3.92 | 19.26 | 7.89 | 36.8 | 8.8 | Upgrade
|
| Operating Cash Flow | 55.76 | 66.87 | 34.26 | -37.25 | 152.55 | 255.42 | Upgrade
|
| Operating Cash Flow Growth | 137.98% | 95.20% | - | - | -40.27% | 300.39% | Upgrade
|
| Capital Expenditures | -63.69 | -45.9 | -174.1 | -128.64 | -176.85 | -79.51 | Upgrade
|
| Sale of Property, Plant & Equipment | 28.58 | 29.18 | 1.23 | 4.95 | 0.54 | - | Upgrade
|
| Divestitures | - | 0.36 | 0.35 | - | - | - | Upgrade
|
| Investment in Securities | 17.99 | 3.6 | -178.46 | 56.71 | -20.21 | -353.36 | Upgrade
|
| Other Investing Activities | -76.77 | 51.27 | 3.47 | 0.76 | 6.57 | 6.3 | Upgrade
|
| Investing Cash Flow | -93.89 | 38.51 | -347.52 | -66.23 | -189.95 | -426.57 | Upgrade
|
| Long-Term Debt Issued | - | 26.69 | 108.82 | 391.97 | 64 | - | Upgrade
|
| Total Debt Issued | 42.77 | 26.69 | 108.82 | 391.97 | 64 | - | Upgrade
|
| Long-Term Debt Repaid | - | -40.99 | -19.94 | -44.87 | -17.25 | -16.68 | Upgrade
|
| Total Debt Repaid | -50.48 | -40.99 | -19.94 | -44.87 | -17.25 | -16.68 | Upgrade
|
| Net Debt Issued (Repaid) | -7.71 | -14.3 | 88.88 | 347.09 | 46.75 | -16.68 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 195.74 | Upgrade
|
| Common Dividends Paid | -14.22 | -13.86 | -5.34 | -12.94 | -100.65 | -18.04 | Upgrade
|
| Other Financing Activities | 3.41 | 0.64 | 3.6 | -1.02 | 0.06 | -20.39 | Upgrade
|
| Financing Cash Flow | -18.52 | -27.52 | 87.14 | 333.13 | -53.85 | 140.64 | Upgrade
|
| Foreign Exchange Rate Adjustments | -7.49 | 0.99 | 1.5 | 4.92 | -0.81 | -4.5 | Upgrade
|
| Net Cash Flow | -64.14 | 78.85 | -224.62 | 234.57 | -92.05 | -35 | Upgrade
|
| Free Cash Flow | -7.93 | 20.97 | -139.85 | -165.89 | -24.29 | 175.92 | Upgrade
|
| Free Cash Flow Margin | -2.92% | 7.97% | -62.36% | -65.29% | -3.54% | 29.44% | Upgrade
|
| Free Cash Flow Per Share | -0.02 | 0.05 | -0.33 | -0.41 | -0.06 | 0.45 | Upgrade
|
| Cash Income Tax Paid | 6.49 | 6.35 | -9.59 | 9.19 | 48.61 | 51.85 | Upgrade
|
| Levered Free Cash Flow | -73.29 | -17.38 | -184.34 | -97.59 | -69.03 | 101.15 | Upgrade
|
| Unlevered Free Cash Flow | -73.29 | -17.38 | -172.68 | -90.94 | -66.47 | 102.64 | Upgrade
|
| Change in Working Capital | -8.88 | -8.88 | -37.05 | -22.54 | -17.71 | -6.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.